Objective To systematically review the literature and assess the diagnostic value of
biomarkers in detection of late-onset left ventricular (LV) dysfunction in childhood cancer …

Aims Childhood cancer therapy is associated with a significant risk of therapy‐related
cardiotoxicity. This meta‐analysis aims to evaluate cardiac biomarkers for the detection of …

Background Childhood cancer survivors at risk for heart failure undergo lifelong
echocardiographic surveillance. Previous studies reported the limited diagnostic accuracy of …

Purpose: To examine the utility and reliability of obtaining early echocardiographic
measurements of left ventricular (LV) remodeling as well as blood biomarkers of cardiac …

Background: The majority of childhood cancer survivors (CCSs) have been exposed to
cardiotoxic treatments and often present with modifiable cardiovascular risk factors. Our aim …

Aim The role that plasma N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and cardiac
troponins T (cTnT) and I (cTnI) play in supplementing imaging to screen for cardiac late …

Purpose Echocardiographic surveillance for asymptomatic left ventricular systolic
dysfunction (ALVSD) is advised in childhood cancer survivors (CCS), because of their risk of …

PURPOSE To leverage baseline global longitudinal strain (GLS) and N-terminal-pro-B-type
natriuretic peptide (NT-proBNP) to identify childhood cancer survivors with a normal left …

Background Childhood cancer survivors (CCSs) have an increased risk of morbidity and
mortality. We evaluated the prevalence and determinants of left ventricular (LV) dysfunction …

Background: Survivors of childhood cancer are at risk for anthracycline-and/or radiotherapy-
induced cardiotoxicity. Aims: The aim of this study was to assess clinical, laboratory, and …